Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called ...

XRPTurbo, the first AI & RWA launchpad built on the XRP Ledger, continues its impressive growth trajectory following its ...

Following a record-breaking presale, XRPTurbo, the revolutionary AI & RWA-focused launchpad for the XRP Ledger, continues to ...

Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis Results from the HERCULES phase 3 study showed delay in disability progression in people ...

RINVOQ is the first and only oral Janus kinase (JAK) inhibitor approved in the European Union (EU) to treat adult patients with giant cell arteritis (GCA) The approval ...